ReviewClinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
Thromboprophylaxis and Perioperative Management of Chronic Anticoagulation in Patients Undergoing Total Hip and Knee Arthroplasty.
Review in Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Total knee arthroplasty (TKA) and total hip arthroplasty (THA) are elective procedures that restore quality of life to patients experiencing pain and/or immobility of end stage osteoarthritis, post-traumatic arthritis, or rheumatoid arthritis. Venous thromboembolism (VTE) includes deep vein thrombosis (DVT) and pulmonary embolism (PE) and is a known complication after joint arthroplasty. Orthopaedic surgeons are as concerned with the complications of postoperative bleeding as they are with the high risk of thrombosis after arthroplasty. Risk stratification allows for patient-specific regimens and has proven to offer both safety and efficacy for thromboprophylaxis, leading to excellent patient outcomes. For patients taking chronic anticoagulants and antiplatelet agents, evidence-based guidelines provide added safety with respect to perioperative management of these medications. Together, surgeons, anesthesiologists, hospitalists, nurses, orthopaedic physician assistants, physical and occupational therapists plus a clinical pharmacy specialist can tailor a medication regimen and discharge plan which is patient-specific, integrating medical evidence with standardized practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.